Concepedia

A multicenter, randomized, double-blind, PLB-controlled trial of Galectin-3 inhibitor (GR-MD-02) in patients with NASH cirrhosis and portal hypertension

Naga Chalasani, G. García-Tsao, Z. Goodman, E.J. Lawitz, Manal F. Abdelmalek, Mary E. Rinella, Mohamed Ryan, Mazen Noureddin, Mariia E. Pyko, Adam Allgood,

Journal of Hepatology · 2018 · 16 citations · 0 references

DOI

Concepts